Ways COVID-19 may impact unrelated pharmacoepidemiologic research using routinely collected data. | Pharmacoepidemiol Drug Saf;30(3): 400-401, 2021 03. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Ways COVID-19 may impact unrelated pharmacoepidemiologic research using routinely collected data.

Webster-Clark, Michael.

Webster-Clark M; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

Pharmacoepidemiol Drug Saf ; 30(3): 400-401, 2021 03.

Article in English | MEDLINE | ID: covidwho-1064406

Subject(s)

COVID-19; SARS-CoV-2; Humans; Pandemics; Pharmacoepidemiology; Routinely Collected Health Data

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Experimental Studies Limits: Humans Language: English Journal: Pharmacoepidemiol Drug Saf Journal subject: Epidemiology / Drug Therapy Year: 2021 Document Type: Article Affiliation country: Pds.5182

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Experimental Studies Limits: Humans Language: English Journal: Pharmacoepidemiol Drug Saf Journal subject: Epidemiology / Drug Therapy Year: 2021 Document Type: Article Affiliation country: Pds.5182